You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR VASCOR


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for VASCOR

Trial ID Title Status Sponsor Phase Start Date Summary
NCT05943821 ↗ The Effect of Allopurinol on the Risk of Cardiovascular Events in Patients With Cardiovascular Risk Recruiting Poznan University of Medical Sciences Phase 3 2023-09-01 Numerous studies, but not all, have suggested a positive effect of allopurinol on the cardiovascular system. The ALL-VASCOR study aims to evaluate the efficacy of allopurinol therapy for improving cardiovascular outcomes in patients at high and very high cardiovascular risk, excluding ischemic heart disease. This is particularly important due to the high cost of cardiovascular disease treatment and its status as one of the leading causes of death.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for VASCOR

Condition Name

Condition Name for VASCOR
Intervention Trials
Uric Acid 1
Cardiovascular Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for VASCOR
Intervention Trials
Cardiovascular Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for VASCOR

Trials by Country

Trials by Country for VASCOR
Location Trials
Poland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for VASCOR

Clinical Trial Phase

Clinical Trial Phase for VASCOR
Clinical Trial Phase Trials
Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for VASCOR
Clinical Trial Phase Trials
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for VASCOR

Sponsor Name

Sponsor Name for VASCOR
Sponsor Trials
Poznan University of Medical Sciences 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for VASCOR
Sponsor Trials
Other 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.